{"id":"W2787038964","doi":"10.1016/s2468-1253(18)30009-8","title":"Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet. Gastroenterology & hepatology","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":168,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; University of Alberta; University of Toronto; Ottawa Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; University of Ottawa; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Boston Biomedical; Cancer Research Institute","keywords":"Placebo; Medicine; Colorectal cancer; Refractory (planetary science); Internal medicine; Oncology; Clinical trial; Cancer; Alternative medicine; Biology; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001238656,0.0005262199,0.001333309,0.0002429536,0.0004576525,0.00002413279,0.0009009891,0.0005967234,0.00155343],"category_scores_gemma":[0.0001303315,0.0004396993,0.0002532475,0.0002831349,0.001964349,0.0001382704,0.0001925097,0.001673894,0.0001539709],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000282624,"about_ca_system_score_gemma":0.0002096822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001107915,"about_ca_topic_score_gemma":0.005474369,"domain_scores_codex":[0.9939393,0.002549633,0.0008456919,0.0008459533,0.0001818265,0.001637554],"domain_scores_gemma":[0.9977205,0.0009309127,0.0004872808,0.0004536956,0.0001532688,0.0002542801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8773881,0.001338304,0.08090284,0.00001795871,0.0005049998,0.0002264854,0.000434499,0.00001265323,0.02206618,0.00008027277,0.01112678,0.005900945],"study_design_scores_gemma":[0.8503135,0.009334443,0.006180503,0.00002174795,0.0003025569,0.0001699488,0.0001672727,0.002618589,0.003933312,0.0001094332,0.1264537,0.0003950128],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814262,0.000397619,0.0001114116,0.00357975,0.01082841,0.001742609,0.000128086,0.0001304239,0.001655432],"genre_scores_gemma":[0.9905947,0.0005280071,0.00009518738,0.005465797,0.002263398,0.0008270562,0.00004449244,0.00004835826,0.0001329886],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1153269,"threshold_uncertainty_score":0.9998055,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1117958393733001,"score_gpt":0.4385704081685156,"score_spread":0.3267745687952155,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}